Sharp AR-207, Руководство по эксплуатации

Страница: 78 / 84

76
Date Issued: Nov. 1, 2000
MATERIAL SAFETY DATA SHEET
MSDS No. F-00991
Section 1. Product Identification
Product:
AR-201NT/T/FT/ST (Black Toner)
Section 2. Supplier’s Name and Address
Sharp Corporation
22-22 Nagaike-cho, Abeno-ku, Osaka, Japan
Local suppliers are listed below. Please contact the nearest supplier for additional information.
(Country) (Name and Telephone Number)
U.S.A. Sharp Electronics Corporation
Telephone number for information: 1-800-237-4277
Emergency telephone number:
1-800-255-3924
Canada Sharp Electronics of Canada Ltd.
Telephone number for information: 905-890-2100
Emergency telephone number:
1-800-255-3924
United Kingdom Sharp Electronics (U.K.) Ltd.
Telephone number for information: 01923-474013
Section 3. Ingredients
Ingredients CAS No. Proportion OSHA PEL ACGIH TLV Other Limits
Styrene-Acrylate copolymer 29497-14-1 > 88 % Not listed Not listed None
Carbon black 1333-86-4 < 6.0% 3.5m g /m
3
3.5m g /m
3
None
Iron oxide 1309-38-2 < 4.5% Not listed Not listed None
Metal Complex dye 109125-51-1 < 1.5% 0.5m g /m
3
0.5m g /m
3
None
109125-50-0
84179-66-8
Section 4. Hazardous Identification (Emergency Overview)
Toner is a fine, black powder possessing no immediate hazard. There are no anticipated carcinogenic effects from
exposure based on animal tests performed using toner. When used as intended according to instructions, studies
do not indicate any symptoms of fibrosis will occur.
Section 5. Health Hazard Data
Route(s) of Entry: Inhalation? Skin? Ingestion?
Yes No Possible but very unusual.
Health Hazards: Acute oral toxicity ------- LDL
0
of this toner is over 2,000m
g
/k
g
.
Mutagenicity ------------- The result of Ames test is negative.
Carcinogenicity: In 1996 the IARC reevaluated carbon black as a Group 2B carcinogen (possible human
carcinogen). This classification is given to chemicals for which there is inadequate human
evidence, but sufficient animal evidence on which to base an opinion of carcinogenicity. The
classification is based upon the development of lung tumors in rats receiving chronic inhalation
exposures to free carbon black at levels that induce particle overload of the lung. Studies
performed in animal models other than rats did not show any association between carbon
black and lung tumors. Moreover, a two-year cancer bioassay using a typical toner preparation
containing carbon black demonstrated no association between toner exposure and tumor
development in rats.
Chronic Effect: In a study in rats of chronic inhalation exposure to a typical toner, a mild to moderate degree of
lung fibrosis was observed in 92% of the rats in the high concentration (16m
g
/m 3 ) exposure
group, and a minimal to mild degree of fibrosis was noted in 22% of the animals in the middle
(4m
g
/m 3 ) exposure group, but no pulmonary change was reported in the lowest (1m
g
/m 3 )
exposure group, the most relevant level to potential human exposures.
Signs and Symptoms of Exposure: Minimal irritation to respiratory tract may occur as with exposure to any
non-toxic dust.
Medical Conditions Generally Aggravated by Exposure: None
Emergency and First Aid Procedures:
Inhalation; Remove to fresh air. If effects occur, consult medical personnel.
Eye;
In case of contact, immediately flush eyes with water for 15 minutes.
{